MRI-determined fat content of human liver, pancreas and kidney

World Journal of Gastroenterology

Volumn 16, Issue 16, 2010, Pages 1993-1998

  Sijens, Paul E ^a   Edens, Mireille A ^a   Bakker, Stephan J L ^a   Stolk, Ronald P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Kidney; Lipids; Liver; Magnetic resonance imaging; Magnetic resonance spectroscopy; Pancreas

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; FAT CONTENT; FEMALE; HUMAN; KIDNEY DISEASE; LIPID KIDNEY LEVEL; LIPID LIVER LEVEL; LIPID PANCREAS LEVEL; LIPID STORAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; SUBCUTANEOUS FAT;

EID: 77951949746     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i16.1993     Document Type: Article

References (25)

1. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92
2. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-5165
3. Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 27-38
4. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 550-562
5. Weinberg JM. Lipotoxicity. Kidney Int 2006; 70: 1560-1566
6. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 3000-3004
7. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008; 29: 351-366
8. Kovanlikaya A, Mittelman SD, Ward A, Geffner ME, Dorey F, Gilsanz V. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol 2005; 35: 601-607
9. Raeder H, Haldorsen IS, Ersland L, Grüner R, Taxt T, Søvik O, Molven A, Njølstad PR. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes 2007; 56: 444-449
10. Schwenzer NF, Machann J, Martirosian P, Stefan N, Schraml C, Fritsche A, Claussen CD, Schick F. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 2008; 43: 330-337
11. Sinha S, Misra A, Rathi M, Kumar V, Pandey RM, Luthra K, Jagannathan NR. Proton magnetic resonance spectroscopy and biochemical investigation of type 2 diabetes mellitus in Asian Indians: observation of high muscle lipids and C-reactive protein levels. Magn Reson Imaging 2009; 27: 94-100
12. Bobulescu IA, Dubree M, Zhang J, McLeroy P, Moe OW. Effect of renal lipid accumulation on proximal tubule Na+/ H+ exchange and ammonium secretion. Am J Physiol Renal Physiol 2008; 294: F1315-F1322
13. Gekle M. Renal tubule albumin transport. Annu Rev Physiol 2005; 67: 573-594
14. Riazi S, Khan O, Tiwari S, Hu X, Ecelbarger CA. Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) abundance in the obese Zucker rat. Am J Nephrol 2006; 26: 245-257
15. Sijens PE. Parametric exploration of the liver by magnetic resonance methods. Eur Radiol 2009; 19: 2594-2607
16. Edens MA, van Ooijen PM, Post WJ, Haagmans MJ, Kristanto W, Sijens PE, van der Jagt EJ, Stolk RP. Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy. Obesity (Silver Spring) 2009; 17: 2239-2244
17. Irwan R, Edens MA, Sijens PE. Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 2008; 18: 806-813
18. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984; 153: 189-194
19. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS. Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. Radiology 2005; 237: 1048-1055
20. Sijens PE, Smit GP, Borgdorff MA, Kappert P, Oudkerk M. Multiple voxel 1H MR spectroscopy of phosphorylase-b kinase deficient patients (GSD IXa) showing an accumulation of fat in the liver that resolves with aging. J Hepatol 2006; 45: 851-855
21. Longo R, Ricci C, Masutti F, Vidimari R, Crocé LS, Bercich L, Tiribelli C, Dalla Palma L. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993; 28: 297-302
22. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994; 12: 487-495
23. Fishbein MH, Mogren C, Gleason T, Stevens WR. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2006; 42: 83-88
24. Kim H, Taksali SE, Dufour S, Befroy D, Goodman TR, Petersen KF, Shulman GI, Caprio S, Constable RT. Comparative MR study of hepatic fat quantification using singlevoxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med 2008; 59: 521-527
25. Palmer AJ, Chung MY, List EO, Walker J, Okada S, Kopchick JJ, Berryman DE. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 2009; 150: 1353-1360